Abbott Laboratories banner

Abbott Laboratories
F:ABL

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
F:ABL
Watchlist
Price: 94.26 EUR -1.16%
Market Cap: €164B

Wall Street
Price Targets

ABL Price Targets Summary
Abbott Laboratories

Wall Street analysts forecast ABL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABL is 115.22 EUR with a low forecast of 96.68 EUR and a high forecast of 140.53 EUR.

Lowest
Price Target
96.68 EUR
3% Upside
Average
Price Target
115.22 EUR
22% Upside
Highest
Price Target
140.53 EUR
49% Upside
Abbott Laboratories Competitors:
Price Targets
9688
Zai Lab Ltd
93% Upside
CAMT
Camtek Ltd
-13% Downside

Revenue
Forecast

5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 14 years the compound annual growth rate for Abbott Laboratories's revenue is 5%. The projected CAGR for the next 3 years is 8%.

Operating Income
Forecast

13% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
13% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

For the last 14 years the compound annual growth rate for Abbott Laboratories's operating income is 13%. The projected CAGR for the next 3 years is 17%.

Net Income
Forecast

2% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss
2% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-28%
Average Miss

For the last 14 years the compound annual growth rate for Abbott Laboratories's net income is 2%. The projected CAGR for the next 3 years is 23%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABL's stock price target?
Price Target
115.22 EUR

According to Wall Street analysts, the average 1-year price target for ABL is 115.22 EUR with a low forecast of 96.68 EUR and a high forecast of 140.53 EUR.

What is Abbott Laboratories's Revenue forecast?
Projected CAGR
8%

For the last 14 years the compound annual growth rate for Abbott Laboratories's revenue is 5%. The projected CAGR for the next 3 years is 8%.

What is Abbott Laboratories's Operating Income forecast?
Projected CAGR
17%

For the last 14 years the compound annual growth rate for Abbott Laboratories's operating income is 13%. The projected CAGR for the next 3 years is 17%.

What is Abbott Laboratories's Net Income forecast?
Projected CAGR
23%

For the last 14 years the compound annual growth rate for Abbott Laboratories's net income is 2%. The projected CAGR for the next 3 years is 23%.

Back to Top